Skip to content
Oncology Research Hub

Texas

Cancer clinical trials in Texas

894 cancer studies are recruiting participants at sites in 75 cities across Texas as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Texas by city

Cities with the most studies recruiting right now.

Every Texas city with a recruiting study

By research area: Lung Cancer (261), Breast Cancer (258), Lymphoma (177), Prostate Cancer (102), Pancreatic Cancer (53), Melanoma (43).

Houston (624), Dallas (243), San Antonio (195), Austin (92), Fort Worth (75), Tyler (41), Irving (39), Sugar Land (34), The Woodlands (28), El Paso (26), Lubbock (21), League City (19), Amarillo (17), Conroe (17), Richardson (16), Abilene (15), Temple (14), Webster (13), Baytown (11), Kingwood (11), Flower Mound (10), Galveston (10), Corpus Christi (9), Cypress (9), Denton (9), McAllen (9), Nassau Bay (9), Palestine (9), Longview (8), Arlington (7), Plano (7), Bedford (6), Denison (6), Odessa (6), Round Rock (6), Waco (6), Allen (5), Grapevine (5), Harlingen (5), Laredo (5), Lewisville (5), McKinney (5), Midland (5), New Braunfels (5), Weslaco (5), Wichita Falls (5), Beaumont (4), Fredericksburg (4), Paris (4), Pearland (4), Edinburg (3), Burleson (2), Fort Sam Houston (2), Forth Worth (2), Humble (2), Spring (2), Weatherford (2), Woodland (2), Anderson (1), Austin, TX 78758 (1), Bellaire (1), Bryan (1), Carrollton (1), Cedar Park (1), Fort Bliss (1), Fort Stockton (1), Frisco (1), Garland (1), Kingswood (1), Kyle (1), Lakeway (1), Nashville (1), Shenandoah (1), Texarkana (1), Woodway (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Texas

Basic details from each study's public record (the 12 most recently updated of 894). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Improving Comprehensive Care of Cancer Patients

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Baylor College of Medicine
    Recruiting in
    Houston
    Registry record
    NCT05323409 · updated
  2. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Houston
    Registry record
    NCT06324357 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Texas on ClinicalTrials.gov.

Lung cancer: recently updated in Texas

  1. JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Texas Southwestern Medical Center
    Recruiting in
    Dallas
    Registry record
    NCT02468024 · updated
  2. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NovoCure GmbH
    Recruiting in
    Dallas · Edinburg · Houston · and 1 more U.S. location
    Registry record
    NCT06216301 · updated
  3. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Tyligand Pharmaceuticals (Suzhou) Limited
    Recruiting in
    Houston · San Antonio
    Registry record
    NCT06385925 · updated
  4. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Houston · Tyler
    Registry record
    NCT06983743 · updated
  5. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    Fort Worth · Houston · Irving
    Registry record
    NCT07277413 · updated
  6. A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    Eikon Therapeutics
    Recruiting in
    Fort Worth
    Registry record
    NCT07365319 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Texas on ClinicalTrials.gov.

Lymphoma: recently updated in Texas

  1. Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT05011045 · updated
  2. Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston · San Antonio
    Registry record
    NCT05676450 · updated
  3. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Temple · The Woodlands · Tyler
    Registry record
    NCT06806033 · updated
  4. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Austin · Dallas
    Registry record
    NCT07221500 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Texas on ClinicalTrials.gov.

Ask about studies in Texas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call